Drug Shortage Report for TARO-DOCUSATE
Report ID | 123219 |
Drug Identification Number | 00716731 |
Brand name | TARO-DOCUSATE |
Common or Proper name | DOCUSATE |
Company Name | TARO PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | DOCUSATE SODIUM |
Strength(s) | 100MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 1000 |
ATC code | A06AA |
ATC description | DRUGS FOR CONSTIPATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-08-15 |
Estimated end date | 2020-10-23 |
Actual end date | 2020-10-26 |
Shortage status | Resolved |
Updated date | 2020-10-27 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-10-27 | French | Compare |
v5 | 2020-10-27 | English | Compare |
v4 | 2020-10-07 | French | Compare |
v3 | 2020-10-07 | English | Compare |
v2 | 2020-08-28 | French | Compare |
v1 | 2020-08-28 | English | Compare |
Showing 1 to 6 of 6